α-catenin expressed in heart and testis
US7341866B2 · kind B2 · utility
0Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 13, 2003 |
| Grant date | Mar 11, 2008 |
| Priority date | — |
| Expiry date | Jun 14, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel α-catenin with a new, specific expression pattern in mainly heart and testis. The invention further relates to the use of this α-catenin in the prediction, diagnosis, and/or treatment of cadherin-catenin related diseases, in particular cardiomyopathies and male infertility.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.